Giardia Detection and Codetection With Other Enteric Pathogens in Young Children in the Vaccine Impact on Diarrhea in Africa (VIDA) Case-Control Study: 2015-2018.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
19 04 2023
Historique:
medline: 21 4 2023
pubmed: 19 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

Giardia has been associated with reduced risk of diarrhea in children in low-resource settings, but the mechanism underlying this association is unknown. To assess whether Giardia may shape colonization or infection with other enteric pathogens and impact associations with diarrhea, we examined Giardia and enteric pathogen codetection among children <5 years old in Kenya, The Gambia, and Mali as part of the Vaccine Impact on Diarrhea in Africa study. We tested for Giardia and other enteric pathogens using enzyme-linked immunosorbent assays and real-time polymerase chain reaction (PCR) on stool, respectively. We evaluated associations between Giardia and enteric pathogen detection using multivariable logistic regression models separately for children with moderate-to-severe diarrhea (MSD, cases) and free of diarrhea (controls). Among 11 039 enrolled children, Giardia detection was more common among controls (35%) than cases (28%, P < .001). Campylobacter coli/jejuni detection was associated with Giardia in controls in The Gambia (adjusted odds ratio [aOR] [95% confidence interval {CI}]: 1.51 [1.22‒1.86]) and cases across all sites (1.16 [1.00‒1.33]). Among controls, the odds of astrovirus (1.43 [1.05‒1.93]) and Cryptosporidium spp. (1.24 [1.06‒1.46]) detection were higher among children with Giardia. Among cases, the odds of rotavirus detection were lower in children with Giardia in Mali (.45 [.30‒.66]) and Kenya (.31 [.17‒.56]). Giardia was prevalent in children <5 years old and was associated with detection of other enteric pathogens, with differing associations in cases versus controls and by site. Giardia may affect colonization or infection by certain enteric pathogens associated with MSD, suggesting an indirect mechanism of clinical impact.

Sections du résumé

BACKGROUND
Giardia has been associated with reduced risk of diarrhea in children in low-resource settings, but the mechanism underlying this association is unknown. To assess whether Giardia may shape colonization or infection with other enteric pathogens and impact associations with diarrhea, we examined Giardia and enteric pathogen codetection among children <5 years old in Kenya, The Gambia, and Mali as part of the Vaccine Impact on Diarrhea in Africa study.
METHODS
We tested for Giardia and other enteric pathogens using enzyme-linked immunosorbent assays and real-time polymerase chain reaction (PCR) on stool, respectively. We evaluated associations between Giardia and enteric pathogen detection using multivariable logistic regression models separately for children with moderate-to-severe diarrhea (MSD, cases) and free of diarrhea (controls).
RESULTS
Among 11 039 enrolled children, Giardia detection was more common among controls (35%) than cases (28%, P < .001). Campylobacter coli/jejuni detection was associated with Giardia in controls in The Gambia (adjusted odds ratio [aOR] [95% confidence interval {CI}]: 1.51 [1.22‒1.86]) and cases across all sites (1.16 [1.00‒1.33]). Among controls, the odds of astrovirus (1.43 [1.05‒1.93]) and Cryptosporidium spp. (1.24 [1.06‒1.46]) detection were higher among children with Giardia. Among cases, the odds of rotavirus detection were lower in children with Giardia in Mali (.45 [.30‒.66]) and Kenya (.31 [.17‒.56]).
CONCLUSIONS
Giardia was prevalent in children <5 years old and was associated with detection of other enteric pathogens, with differing associations in cases versus controls and by site. Giardia may affect colonization or infection by certain enteric pathogens associated with MSD, suggesting an indirect mechanism of clinical impact.

Identifiants

pubmed: 37074432
pii: 7130313
doi: 10.1093/cid/ciac940
pmc: PMC10116554
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S106-S113

Informations de copyright

Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.

Déclaration de conflit d'intérêts

Potential conflicts of interest. All authors report no potential conflicts related to this manuscript. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Références

J Infect Dis. 2017 Aug 1;216(3):305-316
pubmed: 28472348
Int J Parasitol. 2018 Jul;48(8):621-639
pubmed: 29571981
Clin Infect Dis. 2012 Dec;55 Suppl 4:S271-93
pubmed: 23169940
Infect Immun. 2014 Jul;82(7):2772-87
pubmed: 24733096
Trends Parasitol. 2017 Nov;33(11):901-913
pubmed: 28830665
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
J Infect Dis. 2020 Mar 28;221(8):1379-1386
pubmed: 31004129
Am J Epidemiol. 2012 Sep 1;176(5):387-95
pubmed: 22842722
mSphere. 2020 Aug 5;5(4):
pubmed: 32759335
J Clin Microbiol. 2013 Feb;51(2):472-80
pubmed: 23175269
Clin Infect Dis. 2018 Oct 30;67(10):1515-1522
pubmed: 29669039
J Pediatric Infect Dis Soc. 2017 Jun 01;6(2):153-160
pubmed: 28204556
Am J Physiol Gastrointest Liver Physiol. 2016 Apr 15;310(8):G574-85
pubmed: 26744469
Int J Parasitol. 2020 Apr;50(4):263-275
pubmed: 32184085
PLoS Negl Trop Dis. 2011 Jun;5(6):e1158
pubmed: 21666789
Front Microbiol. 2021 Jan 12;11:618106
pubmed: 33510729
Lancet Glob Health. 2021 Mar;9(3):e301-e308
pubmed: 33607029
PLoS One. 2014 Oct 07;9(10):e109087
pubmed: 25289678
Lancet Glob Health. 2015 Sep;3(9):e564-75
pubmed: 26202075
Lancet Infect Dis. 2019 Jul;19(7):717-727
pubmed: 31178289
MMWR Morb Mortal Wkly Rep. 2021 Mar 05;70(9):304-307
pubmed: 33661866
Eur J Epidemiol. 2004;19(9):877-83
pubmed: 15499898
J Water Health. 2007 Mar;5(1):1-38
pubmed: 17402277
Int J Parasitol. 2017 May;47(6):311-326
pubmed: 28237889
Am J Pathol. 2017 Nov;187(11):2486-2498
pubmed: 28823873

Auteurs

Perrine Marcenac (P)

Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Awa Traoré (A)

Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.

Sunkyung Kim (S)

Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Graeme Prentice-Mott (G)

Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

David M Berendes (DM)

Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Helen Powell (H)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Irene N Kasumba (IN)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Dilruba Nasrin (D)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Joquina Chiquita M Jones (JCM)

Medical Research Council (UK) Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.

Syed M A Zaman (SMA)

Medical Research Council (UK) Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.

John B Ochieng (JB)

Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.

Jane Juma (J)

Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.

Doh Sanogo (D)

Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.

Marc-Alain Widdowson (MA)

Division of Global Health Protection, Center for Global Health, Nairobi, Kenya.

Jennifer R Verani (JR)

Division of Global Health Protection, Center for Global Health, Nairobi, Kenya.

Jie Liu (J)

Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
School of Public Health, Qingdao University, Qingdao, China.

Eric R Houpt (ER)

Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.

M Jahangir Hossain (M)

Medical Research Council (UK) Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.

Samba O Sow (SO)

Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.

Richard Omore (R)

Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.

Sharon M Tennant (SM)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Eric D Mintz (ED)

Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Karen L Kotloff (KL)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH